Jian Qu

3.1k total citations
98 papers, 2.0k citations indexed

About

Jian Qu is a scholar working on Molecular Biology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Jian Qu has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 15 papers in Pharmacology and 15 papers in Psychiatry and Mental health. Recurrent topics in Jian Qu's work include Epilepsy research and treatment (14 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antibiotic Resistance in Bacteria (11 papers). Jian Qu is often cited by papers focused on Epilepsy research and treatment (14 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antibiotic Resistance in Bacteria (11 papers). Jian Qu collaborates with scholars based in China, United States and Tunisia. Jian Qu's co-authors include Audrey Minden, Qiang Qu, Nerina Gnesutta, Qiong Lu, Zhaoqian Liu, Boting Zhou, Haihong Zhu, Ji‐Ye Yin, Tingting Qi and Jiaojiao Wang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Jian Qu

97 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Qu China 24 1.1k 439 268 228 190 98 2.0k
Tomoji Maeda Japan 30 799 0.8× 630 1.4× 103 0.4× 47 0.2× 303 1.6× 77 2.1k
Ran Gao China 23 769 0.7× 203 0.5× 283 1.1× 65 0.3× 49 0.3× 98 1.7k
Rajgopal Govindarajan United States 26 883 0.8× 539 1.2× 276 1.0× 27 0.1× 170 0.9× 49 2.1k
Jing Lü China 28 1.3k 1.2× 556 1.3× 525 2.0× 44 0.2× 47 0.2× 152 2.6k
Ting C. Zhao United States 33 1.9k 1.8× 365 0.8× 249 0.9× 38 0.2× 53 0.3× 106 2.9k
Jing Yang China 26 741 0.7× 123 0.3× 453 1.7× 53 0.2× 238 1.3× 150 2.3k
Liang Liu China 30 1.3k 1.2× 884 2.0× 411 1.5× 50 0.2× 32 0.2× 136 2.9k
Weimin Sun United States 26 728 0.7× 220 0.5× 188 0.7× 43 0.2× 86 0.5× 88 1.9k
Huakan Zhao China 17 1.5k 1.5× 661 1.5× 633 2.4× 73 0.3× 26 0.1× 38 3.2k
Yuewen Gong Canada 33 1.5k 1.4× 367 0.8× 393 1.5× 48 0.2× 64 0.3× 127 3.1k

Countries citing papers authored by Jian Qu

Since Specialization
Citations

This map shows the geographic impact of Jian Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Qu more than expected).

Fields of papers citing papers by Jian Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Qu. The network helps show where Jian Qu may publish in the future.

Co-authorship network of co-authors of Jian Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Qu. A scholar is included among the top collaborators of Jian Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Qu. Jian Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wen‐Ying, et al.. (2025). The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy. Journal of Inflammation Research. Volume 18. 4335–4357. 15 indexed citations
2.
Qiu, Yue, Wei Wang, Hainan Zhang, et al.. (2025). Prolonged versus short-term infusion of meropenem for the treatment of sepsis: a systematic review and meta-analysis. International Journal of Surgery. 111(10). 7213–7221.
3.
Wang, Yao, et al.. (2024). Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report. Frontiers in Cellular and Infection Microbiology. 14. 1380312–1380312. 3 indexed citations
4.
Qu, Qiang, et al.. (2024). The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers. International Journal of Biological Sciences. 20(5). 1652–1668. 14 indexed citations
5.
Ma, Hongying, Sihui Huang, Jian Luo, et al.. (2024). Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy. Archives of Toxicology. 98(9). 3049–3061. 23 indexed citations
6.
Qu, Qiang, et al.. (2023). Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature. European Journal of Pediatrics. 183(1). 51–60. 13 indexed citations
7.
Qu, Qiang, et al.. (2023). Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer. Frontiers in Pharmacology. 14. 1192855–1192855. 5 indexed citations
8.
Li, Hang, Jian Qu, Haihong Zhu, et al.. (2021). CGRP Regulates the Age-Related Switch Between Osteoblast and Adipocyte Differentiation. Frontiers in Cell and Developmental Biology. 9. 675503–675503. 26 indexed citations
9.
Qu, Jian, Shengyu Tan, Xinyan Xie, et al.. (2021). Dendrobium Officinale Polysaccharide Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Obese Mice. Frontiers in Pharmacology. 12. 659626–659626. 42 indexed citations
10.
Lu, Qiong, Haihong Zhu, Tingting Qi, et al.. (2021). A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections. Frontiers in Medicine. 8. 620885–620885. 15 indexed citations
11.
Qu, Jian, Gefei He, Juanjuan Huang, et al.. (2020). Comparative effectiveness of Lopinavir/Ritonavir‐based regimens in COVID‐19. Clinical and Experimental Pharmacology and Physiology. 48(2). 203–210. 8 indexed citations
12.
Long, Hongyu, Mengqi Zhang, Yanjing Wang, et al.. (2019). Glutathione S-transferase genes variants and glioma risk: A case-control and meta-analysis study. Journal of Cancer. 10(19). 4679–4688. 9 indexed citations
14.
Qu, Qiang, Jian Qu, Zigui Chen, et al.. (2015). Common Variants of KCNJ10 Are Associated with Susceptibility and Anti-Epileptic Drug Resistance in Chinese Genetic Generalized Epilepsies. PLoS ONE. 10(4). e0124896–e0124896. 27 indexed citations
15.
Qu, Qiang, Jian Qu, Yong Guo, Boting Zhou, & Hong‐Hao Zhou. (2014). Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway. Anti-Cancer Drugs. 25(9). 1016–1027. 24 indexed citations
16.
Qu, Jian, Ying Zhang, Xiao‐Yuan Mao, et al.. (2013). Gene‐Wide Tagging Study of the Association Between KCNT1 Polymorphisms and the Susceptibility and Efficacy of Genetic Generalized Epilepsy in Chinese Population. CNS Neuroscience & Therapeutics. 20(2). 140–146. 17 indexed citations
17.
Zhou, Boting, Ji‐Ye Yin, Guoliang Li, et al.. (2012). Effects of SCN1A and GABA Receptor Genetic Polymorphisms on Carbamazepine Tolerability and Efficacy in Chinese Patients with Partial Seizures: 2‐Year Longitudinal Clinical Follow‐Up. CNS Neuroscience & Therapeutics. 18(7). 566–572. 41 indexed citations
18.
Xu, Xiaojing, Qi Pei, Jian Qu, et al.. (2011). Effect of nicotinamide mononucleotide on insulin secretion and gene expressions of PDX-1 and FoxO1 in RIN-m5f cells.. PubMed. 36(10). 958–63. 5 indexed citations
19.
Gong, Zhicheng, Guanghua Lei, Lan Fan, et al.. (2011). Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2. Clinical and Experimental Pharmacology and Physiology. 38(12). 824–829. 18 indexed citations
20.
Qu, Jian, et al.. (2001). Activated PAK4 Regulates Cell Adhesion and Anchorage-Independent Growth. Molecular and Cellular Biology. 21(10). 3523–3533. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026